Interest of a third dose of BNT162b2 anti‐SARS‐CoV‐2 messenger RNA vaccine after allotransplant
Abstract
No abstract available
Elizabeth Bernardo : Connect in order to contact the contributor
https://www.hal.inserm.fr/inserm-03542571
Submitted on : Tuesday, January 25, 2022-2:09:47 PM
Last modification on : Wednesday, November 23, 2022-6:10:04 PM
Long-term archiving on: Tuesday, April 26, 2022-6:54:53 PM